Product image of Aranesp (Darbepoetin Alfa) supplied by GNH India

Aranesp

Active Ingredient:
Darbepoetin Alfa
Origin:
EU

Aranesp (Darbepoetin Alfa)

Aranesp (Darbepoetin Alfa) is a medication used to stimulate red blood cell production. It is commonly prescribed for conditions related to low red blood cell counts, such as anemia associated with chronic kidney disease.

Manufacturer / TM Owner

Amgen Europe B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Aranesp is primarily used to treat anemia in patients with chronic kidney disease who are on dialysis or not on dialysis. It works by stimulating the bone marrow to produce more red blood cells, which can help improve energy levels and reduce fatigue. The medication is administered via subcutaneous injection, as directed by a healthcare provider.

Side Effects

  • Common effects of Aranesp may include injection site reactions, such as redness or swelling. Some users might experience flu-like symptoms, such as fever or chills. It is important to monitor for any signs of allergic reactions, which can include rash, itching, or difficulty breathing.

Precautions & Warnings

  • Aranesp should be used with caution in patients with a history of heart problems, high blood pressure, or seizures. It is essential to follow the prescribed dosage and administration schedule to minimize the risk of side effects. Regular blood tests may be required to monitor red blood cell levels and adjust treatment as needed.

Avoid Interactions

  • Aranesp may interact with other medications, including certain antibiotics, anticonvulsants, and immunosuppressants. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, alcohol consumption should be moderated, as it can affect the body's response to the medication.

Frequently Asked Questions

Aranesp is used to treat anemia in patients with chronic kidney disease, helping to stimulate red blood cell production.

Aranesp is typically administered via subcutaneous injection, as prescribed by a healthcare provider.

Common side effects may include injection site reactions, flu-like symptoms, and allergic reactions.

Aranesp may interact with certain medications, so it is important to consult a healthcare provider before combining it with other treatments.

Aranesp should be stored as directed by the manufacturer, typically in a refrigerator between 2°C to 8°C.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Darbepoetin Alfa

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT